Myriad Genetics increases revolving credit facility by $25M to $115M, adds Goldman Sachs as lender

MYRIAD GENETICS INC

Revolving credit facility raised from $90M to $115M; $25M new commitment from Goldman Sachs Bank USA.
Amendment consents to South Chipeta lease assignment and sale of office furniture/equipment (value ≤$4.3M).
Extended deadline for compliance with certain post-closing obligations of the original credit agreement.
Loan parties reaffirm guarantees and security interests; Lien on South Chipeta personal property to be released.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.